Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00625131 · ClinicalTrials.gov registry record · Early Phase 1
Nicotine Patch Pretreatment for Smoking Cessation in PTSD
A Early Phase 1 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 87
- Enrollment target
NCT00625131 is a Early Phase 1 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 87 participants.
The verdict
NCT00625131, a Early Phase 1 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 87 participants
- Enrollment target
Study Summary
This study seeks to evaluate the relationship between PTSD, abstinence, and factors associated with relapse in the context of a randomized, clinical smoking cessation trial.
Interventions
- DRUG Nicotine
- DRUG Placebo patch
- BEHAVIORAL Cognitive Behavioral Therapy for Smoking Cessation
- DRUG Bupropion Sustained Release (SR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2008-05 |
| Est. Completion | 2013-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00625131
The ClinicalTrials.gov registry entry for NCT00625131 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nicotine is the first listed.
NCT00625131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00625131 about?
NCT00625131 is a clinical study titled "Nicotine Patch Pretreatment for Smoking Cessation in PTSD". This study seeks to evaluate the relationship between PTSD, abstinence, and factors associated with relapse in the context of a randomized, clinical smoking cessation trial.
What is the current status of trial NCT00625131?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 87 participants. The study started on 2008-05. Estimated completion is 2013-03.
What interventions are being tested in trial NCT00625131?
The interventions under investigation include: Nicotine (DRUG), Placebo patch (DRUG), Cognitive Behavioral Therapy for Smoking Cessation (BEHAVIORAL), Bupropion Sustained Release (SR) (DRUG).
Who is sponsoring clinical trial NCT00625131?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.